APPLICATIONS PUBLISHED 21 JANUARY 2004
Published: 1-Jun-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Method for the continuous production of medicaments for inhalation
Boehringer Ingelheim 1381351*
Transdermal patch for administering fentanyl
Alza 1381352*
Ipratropium formulation for pulmonary inhalation
Pharmascience 1381353*
Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
Sangstat Medical Corp 1381354*
Matrix metalloproteinase inhibitors
Kimberly-Clark 1381355*
Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
Aventis Pharmaceuticals 1381356*
Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydroganse activity
Sterix 1381357*
Solid pharmaceutical compsn comprising 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-M toluide and PVP
AstraZeneca 1381358*
Aurones as telomerase inhibitors
Pharmacia Italia 1381359*
Compounds and methods for inhibiting metaP2 in mammals
SmithKline Beecham 1381360*
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
Ortho McNeil Pharmaceutical 1381361*
Pharmaceutical compsn comprising clavulanic acid
Sandoz 1381362*
Imidazo [1,2-A]-pyridine derivatives as MGLUR5 antagonists
F Hoffmann-La Roche 1381363*
Use of mangafodipir for treating oxidative stress effects
Universite Rene Derscartes 1381364*
Pyrrolidine sulphonamides
SmithKline Beecham 1381365*
Indole, azaindole and related heterocyclic amidopiperazine derivatives
Bristol-Myers Squibb 1381366*
Aripiprazole oral solution
Bristol-Myers Squibb 1381367*
Compsns containing imidazotriazinone for nasal application
Bayer 1381368*
Use of selective COX-2 inhibitors for the treatment of urinary incontinence
Recordati Industria Chimica e Farmaceutica 1381369*
N-biphenylcarbonyl- and N-phenylpyridinylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressin agonists
Wyeth 1381370*
Hormone replacement therapy
Wyeth 1381371*
Substituted tetracycline compounds as synergistic antifungal agents
Paratek Pharmaceuticals 1381372*
A method for treating or preventing a functional vitamin B12 deficiency in an individual and medical compsns for use in said method
Coblaz 1381373*
Veterinary compsns comprising avermectin-oxime derivatives and praziquantel
Pfizer 1381374*
Oligonucleotide compsns and their use to induce differentiation of cells
Bioniche Life Science 1381375*
In vivo use of water absorbent polymers
Dow Global Technologies 1381376*
A compsn including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
AKL Technologies 1381377*
Compsns and methods for cancer prevention and treatment derived from Inula britannica
Rutgers, the State University of New Jersey 1381378*
Hop extracts and use thereof in the production of a medicament having estrogenic properties
Berkem 1381379*
Pharmaceutical compsn containing bulbophyllum
Barthel, Michael 1381380*
Patch for transcutaneous immunisation
Glenn, Gregory; Yu, Jianmel; Hamer, Mervyn; Miranda, Jesus; Adams, Christopher; Iomai Corp 1381381*
Methods and compsns for the treatment of diseases of the eye
Merck Patent 1381382*
Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
Clontech Laboratories 1381383*
Combination therapy using anti-angiogenic agents and TNFA
Merck Patent 1381384*
Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability
Aventis Pharma Deutschland 1381385*
Novel mixtures of microbial enzymes
Solvay Pharmaceutical 1381386*
Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases
Wank, Rudolf 1381387*
Production of peptides in plants as N-terminal viral coat protein fusions
Large Scale Biology Corp 1381388*
Smallpox vaccine
Acambis 1381389*
Mulitvalent vaccine comprising an HIV antigen and an HSV antigen and/or an HPV antigen
GlaxoSmithKline Biologicals 1381390*
Vaccines including as an adjuvant type 1 IFN and processes related thereto
Istituto Superiore di Sanita 1381391*
Synthetic catalyst for selective cleavage of protein and method for selecting cleavage of protein using the same
TS Corp 1381392*
Microparticle protection of therapeutic agents
Scimed Life Systems 1381393*
Biomaterials comprising a melanocyte stimulating hormone (MSH), and method of forming
The University of Sheffield 1381394*
Systems, methods and devices for in vivo monitoring of a localised response via a radiolabelled analyte in a subject
Sicel Technologies 1381395*
TC and RE labelled radioactive glycosylated octreotide derivatives
Mallinckrodt 1381396*
Stabilisation of radiopharmaceutical compsns using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
Diatide 1381397*
